W. David Lee - CEO

David has over 35 years of experience translating innovation into commercial successes. As a senior vice president and managing director at Arthur D. Little (ADL), he directed the technology and product development division, one of three major ADL business lines, and personally managed over 50 development programs during his tenure. David and his associates taught product development and commercialization skills to Fortune 500 companies including ABB, General Electric, Carrier and Analog Devices. David has founded several companies including T2 Biosystems and Caveo. He has a B.S. and an M.S. in Mechanical Engineering from Massachusetts Institute of Technology and completed the intensive Advanced Management Program at Harvard Business School.



Jorge Ferrer Ph.D. - Senior Vice President of Research & Development

Jorge leads the company's research and development efforts including planning and overseeing the work with Lumicell’s academic collaborators, managing pre-clinical and clinical studies, and communicating and reporting to the FDA. During his post-doctoral with Dr. Moungi Bawendi at Massachusetts Institute of Technology, he developed the prototype of the Lumicell imaging system and conducted the proof-of-concept experiments in mice and dogs. He holds a Ph.D. from Massachusetts Institute of Technology in Biological Engineering, an M.S. and a B.S. from Massachusetts Institute of Technology in Mechanical Engineering. Prior to his post-graduate studies, Jorge worked as a Mechanical Design Engineer in the sensors and controls industry at Texas Instruments.



Bill Johnson - CFO

Bill works on the various financial and operational matters involved in bringing Lumicell technology to market. In addition to his role at Lumicell, Bill is also the VP of Finance at GreenLight Biosciences. Previously, Bill was the CFO of Allegro Diagnostics, which was acquired by Veracyte in 2014. Bill has also held roles at Kodiak Venture Partners, Cue Ball Capital, Summit Partners, and began his career at PricewaterhouseCoopers. Bill is also a Certified Public Accountant in Massachusetts. Bill received his M.B.A. from Boston College’s Carroll School of Management and a B.A. in Economics-Accounting from the College of the Holy Cross.



David Strasfeld Ph.D. - Director, Research and Development

David is developing the next generation of Lumicell imaging devices for clinical use, pursuing new indications for the Lumicell technology and ensuring regulatory compliance throughout the development process. David holds a B.A. from Washington University in St. Louis in chemistry and a Ph.D. from the University of Wisconsin – Madison in physical chemistry. David joined Lumicell following time spent as a post-doctoral associate at Massachusetts Institute of Technology in the lab of Moungi Bawendi. David has co-authored over 20 journal articles and reviews in the fields of biophysics, molecular spectroscopy and fluorescence microscopy.